Highlights genedrive plc

Equities

Market Closed - London S.E. Other stock markets 11:35:07 2024-05-03 am EDT			5-day change	1st Jan Change
4.375 ^GBX	-0.57%		-18.60%	-46.15%

Apr. 24	Genedrive enters clinical trial deal in US for MT-RNR1 US approval	AN
Apr. 03	FTSE 100 up thanks to US economic data	AN

Genedrive enters clinical trial deal in US for MT-RNR1 US approval	Apr. 24	AN
FTSE 100 up thanks to US economic data	Apr. 03	AN
EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate	Mar. 28	AN
Genedrive plc Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 28	CI
Genedrive down as plans equity raise despite GBP800,000 tax credit	Mar. 15	AN
Coro seals sale terms, Powerhouse makes good progress	Feb. 19	AN
Genedrive Seeks Funding for Testing Kit Amid Funding Call Launch of UK-backed Program	Feb. 19	MT
MoneySupermarket credits Insurance for growth in 2023	Feb. 19	AN
Genedrive draws down GBP600,000 on prepayment facility	Jan. 02	AN
Genedrive shares surge as six countries receive first orders	Dec. 20	AN
Genedrive Jumps on Receipt of Initial Orders for MT-RNR1 Products	Dec. 20	MT
Genedrive plc Announces Initial Overseas Orders of Mt-RNR1 Id Kit	Dec. 20	CI
600 Group disposal and funding talks continue	Dec. 04	AN
Genedrive plc Announces the Genedrive MT-RNR1 Id Kit Is Now in Routine Use in the Trevor Mann Baby Unit	Dec. 04	CI
Genedrive shares fall as annual loss widens but focused on investing	Nov. 30	AN
Earnings Flash (GDR.L) GENEDRIVE Reports FY23 Revenue GBP55,000	Nov. 30	MT
Earnings Flash (GDR.L) GENEDRIVE Posts FY23 Loss GBX-5.50	Nov. 30	MT
Genedrive plc Reports Earnings Results for the Full Year Ended June 30, 2023	Nov. 30	CI
EARNINGS AND TRADING: Southern Energy loss swing; Craven House widens	Nov. 29	AN
Genedrive Shares Surge With UKCA Marking Registration for Pharmacogenomic Test	23-09-06	MT

No results for this search